Covid vaccine: India begins testing indigenous candidate at PGIMS, Rohtak
Updated on Jul 18, 2020 08:15 am IST
Human trials of a Covid vaccine candidate, developed in India, have begun. Trials of the drug named Covaxin are being conducted at PGIMS, Rohtak. Bharat Biotech and ICMR's National Institute of Virology, Pune developed Covaxin. The other trial vaccine developed in India is Zydus Cadila's ZyCov-D. The trials are being conducted as India's total case tally has crossed 10 lakh-mark.
RELATED VIDEOS
Watch: PM Nehru's last-ever Independence Day speech | 1963
Published on Aug 01, 2026 08:22 pm IST
1948 Independence Day speech: What Nehru said on religious hate on 1st I-Day
Published on Jul 31, 2026 05:13 pm IST
Israel’s UN envoy tries to turn Mamdani into the enemy?
Published on Jul 29, 2026 08:25 pm IST
New anti-exam paper leak bill in parliament: minister lists measures
Published on Jul 28, 2026 05:14 pm IST
From Rahul Gandhi to Arvind Kejriwal: Opposition leaders salute youth
Published on Jul 25, 2026 05:41 pm IST
Dharmendra Pradhan resigns as NEET leak protests hit boiling point
Published on Jul 25, 2026 04:15 pm IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}